在轻度血小板功能障碍中,作为出血表型指标的前列血消耗
Antoine Babuty1,2, Camille Debord1, Nicolas Drillaud1,2
1Nantes Université, CHU Nantes, Service d'Hématologie Biologique, Nantes, France.
在轻度血小板功能障碍中评估出血风险具有挑战性. 增加的前热血素消耗,即凝血的衡量标准,与患有这些疾病的患者的更高的出血分数相关.
科学领域:
- 血液学 血液学 血液学
- 临床病理学 临床病理学
背景情况:
- 轻微的血小板功能障碍带来了诊断上的挑战.
- 在这些患者中评估出血风险是复杂的,因为表型未被充分探索.
研究的目的:
- 为患有轻度血小板功能障碍的患者建立全面的生物学表型.
- 为了确定与异常出血分数相关的实验室分析.
主要方法:
- 包括20名患有持续异常光传输聚合度 (LTA) 的患者.
- 使用了国际血栓和血液静止学会出血评估工具 (ISTH-BAT).
主要成果:
- 没有LTA或流细胞计参数与异常出血得分相关.
- 在异常ISTH-BAT得分的患者中,前列血消耗显著增加 (p=0.006).
- 输血红素消耗与ISTH-BAT得分有显著的关联 (r=0.5287,p=0.0165).
结论:
- 在轻微的血小板功能障碍中,病理性出血得分与增加的前热血素消耗有关.
- 血栓消耗可能作为与出血风险相关的血小板功能异常的额外指标.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
相关概念视频
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
